The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Health Equity
Learn more about our Health Equity work.
Building the Business Case for Health Equity
Relive highlights from AdvaMed®’s latest Health Equity webinar, Building the Business Case for Health Equity. Discover why it’s critical for medtech organizations to prioritize equity in their business strategies.
First Opinion readers on cancer screening, mpox vaccines, and more
The op-ed unfairly and dangerously diminishes the value of cancer screening in reducing health disparities. As the writers acknowledge, numerous, complex factors contribute to poorer outcomes for Black patients than…
Recruiting and Retaining Diverse Clinical Research Participants – Member Best Practices
AdvaMed® is engaged in efforts to ensure our industry is doing its part to mitigate the adverse impacts of health disparities among people and communities of color.
Racial and Gender Equity in Health Care: a Wake-up Call and an Opportunity
Two important developments just happened on the health equity and diversity front. One, the American Heart Association released a ground-breaking study finding women’s cardiovascular health is perhaps more poorly understood…
NEW EPISODE: Medtech POV with Scott Whitaker | American Heart Association CEO Nancy Brown on the Evolution of Cardiovascular Care, Important Role of Medical Technology
In the latest episode of Medtech POV, Nancy Brown, Chief Executive Officer of the American Heart Association, joins host Scott Whitaker to talk about her journey to leading one of…
Prioritizing Heart Health in Women Across the Health System
Heart disease is the leading cause of death for both men and women in the United States, but historically—and even today—women are underrepresented in heart disease research, can be overlooked…
Racial and Ethnic Diversity in FDA Regulated Clinical Trials
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
Women’s Health Equity Initiative
AdvaMed® is dedicated to ensuring our industry focuses their efforts on treating and raising the awareness of women’s health conditions.
Phase III: Disparities in Access to Selected Advanced Medical Procedures in the Medicare Population
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.